Clinical Trials on Hematopoietic Stem Cell Transplant in New Zealand

Total 133 results

Memorial Sloan Kettering Cancer Center

Terminated

T-cell Depleted Hematopoietic Stem Cell Boosts Without Conditioning for Poor Marrow Graft Function Following Allogeneic Hematopoietic Stem Cell Transplantation

Hematopoietic Stem Cell Transplant | Poor Marrow Graft Function

United States
Memorial Sloan Kettering Cancer Center
Weill Medical College of Cornell University

Completed

International Travel Patterns and Health Preparations of Hematopoietic Stem Cell Transplant Recipients at Memorial Sloan-Kettering Cancer Center

Hematopoietic Stem Cell Transplant

United States
Memorial Sloan Kettering Cancer Center
City University of New York

Active, not recruiting

Adaptation of Skills Training Manuals for Patients Receiving Hematopoietic Stem Cell Transplantation and Their Caregivers

Post Hematopoietic Stem Cell Transplantation

United States
Dartmouth-Hitchcock Medical Center

Recruiting

Early Chimerism Following Allogeneic Stem-Cell Transplant

Allogeneic Stem-Cell Transplant

United States
Dartmouth-Hitchcock Medical Center

Completed

Patient Reported Outcomes and Patient Education in Cellular Therapy Patients

Lymphoma | Leukemia | Multiple Myeloma | Stem Cell Transplant | Hematopoietic Stem Cell Transplant | CAR T-Cell Therapy | HSCT | Cellular Therapy | CAR T-Cell Transplant

United States
Medical College of Wisconsin
National Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaborators

Completed

Prospective Cohort for the Evaluation of Biomarkers Following HCT (BMT CTN 1202)

Allogeneic Hematopoietic Stem Cell Transplantation

United States
Memorial Sloan Kettering Cancer Center

Recruiting

Collecting Dietary Information From People Undergoing Cancer Treatment

Receiving Allogeneic Hematopoietic Cell Transplants

United States
Memorial Sloan Kettering Cancer Center

Completed

Telemedicine Evaluation for Stem Cell Transplant Patients

Stem Cell Transplant Patients

United States
Takeda

Completed

Dose Finding Study of Vedolizumab for GvHD in Participants Undergoing Allogeneic HSCT

Allogeneic Hematopoietic Stem Cell Transplantation

United States
Center for International Blood and Marrow Transplant...
University of Pittsburgh; National Institutes of Health (NIH); University of...

Completed

Stem Cell Related Donor Safety Study (RDSafe)

Related Hematopoietic Stem Cell Donors

United States
Center for International Blood and Marrow Transplant...
Medical College of Wisconsin

Completed

Feasibility of Collecting Quality of Life Data in Collaboration With the Stem Cell Therapeutic Outcomes Database (09-SQOL)

Hematopoietic Stem Cell Transplantation

United States
Center for International Blood and Marrow Transplant...
Patient-Centered Outcomes Research Institute; National Marrow Donor Program

Completed

Randomized Study of Individualized Care Plans for Hematopoietic Cell Transplant Survivors

Adult Hematopoietic Cell Transplant (HCT) Survivors 1-2 Yrs Post Most Recent HCT

United States
University Hospital Muenster
Merck Sharp & Dohme LLC; Gilead Sciences

Completed

A Study of Caspofungin, Liposomal Amphotericin B or the Combination of Both for Patients After Stem-Cell Transplantation

Hematopoietic Stem Cell Transplantation | Fungus Diseases

Germany
Atara Biotherapeutics

Recruiting

Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) After Failure of Rituximab or Rituximab and Chemotherapy (ALLELE)

Lymphoproliferative Disorders | Stem Cell Transplant Complications | Solid Organ Transplant Complications | Allogeneic Hematopoietic Cell Transplant | Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD)

United States, Austria, Australia, Belgium, Canada, France, Italy, Spain, United Kingdom
Seres Therapeutics, Inc.
Memorial Sloan Kettering Cancer Center

Recruiting

A Multiple Dose Study to Evaluate Safety, Tolerability, PK, and Efficacy of SER-155 in Adults Undergoing HSCT

Allogeneic Hematopoietic Stem Cell Transplantation

United States
Roswell Park Cancer Institute
Amgen

Completed

Denosumab in Treating Patients With Bone Loss Due to Donor Stem Cell Transplant

Osteoporosis | Osteopenia | Allogeneic Hematopoietic Stem Cell Transplantation Recipient

United States
Memorial Sloan Kettering Cancer Center

Active, not recruiting

Autologous Fecal Microbiota Transplantation (Auto-FMT) for Prophylaxis of Clostridium Difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation

Allogeneic Hematopoietic Stem Cell

United States
Omeros Corporation

Recruiting

Efficacy and Safety Study of Narsoplimab in Pediatric Patients With High-Risk Hematopoietic Stem Cell Transplant TMA

Thrombotic Microangiopathies | Hematopoietic Stem Cell Transplantation

United States, Germany, Israel, Netherlands, Spain
Millennium Pharmaceuticals, Inc.

Terminated

A Dose-Finding Study of Vedolizumab for Treatment of Steroid-Refractory Acute Intestinal Graft-Versus-Host Disease (GvHD) in Participants Who Have Undergone Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT)

Allogeneic Hematopoietic Stem Cell Transplantation

United States, Belgium, Sweden, France, Norway
St. Jude Children's Research Hospital
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting

Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients

Solid Organ Transplant | Respiratory Viral Infection | Hematopoietic Cell Transplant

United States
Montefiore Medical Center
Nationwide Children's Hospital; Children's Hospital Los Angeles

Terminated

A Multi-Institutional Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Malignant Neuro-Epithelial and Other Solid Tumors

Solid Tumor | Allogeneic Hematopoietic Stem Cell Transplantation | Neuroepithelial Tumor

United States
Bristol-Myers Squibb

Completed

A Study to Assess 7/8 HLA-matched Hematopoietic Stem Cell Transplantation Participants Treated With or Without Abatacept in Combination With a Calcineurin Inhibitor and Methotrexate

Stem Cell Transplantation

United States
Memorial Sloan Kettering Cancer Center
Merck Sharp & Dohme LLC

Recruiting

A Study of the Drug Letermovir (LTV) as Prevention for Recurrent of Cytomegalovirus (CMV) Infection

CMV | CMV Infection | Hematopoietic Cell Transplant

United States
Weill Medical College of Cornell University
National Cancer Institute (NCI)

Recruiting

Delirium in Children Undergoing Stem Cell Transplantation

Delirium | Stem Cell Transplant Complications

United States, Canada
Icahn School of Medicine at Mount Sinai
National Cancer Institute (NCI); University of California, San Diego; Hackensack...

Completed

Treating Cancer-Related Fatigue Through Systematic Light Exposure

Quality of Life | Breast Cancer | Fatigue | Sleep | Mild Cognitive Impairment | Hematopoietic Stem Cell Transplantation | Light

United States
Eli Lilly and Company

Completed

A Safety Evaluation of Drotrecogin Alfa (Activated) in Patients With Blood Cancer, Severe Infection Related to Bone Marrow Transplantation

Sepsis | Hematologic Neoplasms | Infection | Hematopoietic Stem Cell Transplantation

United States
Millennium Pharmaceuticals, Inc.

Completed

Vedolizumab in the Prophylaxis of Intestinal Acute Graft Versus Host Disease (aGVHD) in Participants Undergoing Allogeneic Hematopoietic Stem Cell (Allo-HSCT) Transplantation

Hematopoietic Stem Cells

United States, Spain, Taiwan, Australia, Canada, Singapore, Korea, Republic of, Mexico, Switzerland, Japan, Germany, Norway, Israel, Russian Federation, Hungary, United Kingdom, Italy, Romania, Brazil, France, Austria, Belgium, Port... and more
Center for International Blood and Marrow Transplant...

Recruiting

Protocol for a Research Sample Repository for Hematopoietic Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries

Allogeneic Stem Cell Transplantation | Autologous Stem Cell Transplantation | Cellular Therapy | Marrow Toxic Injury

United States
National Center for Complementary and Integrative...
National Cancer Institute (NCI)

Completed

The Effects of Music Therapy-Based Stress Reduction on Bone Marrow Transplant Recipients

Stem Cell Transplantation | Bone Marrow Transplantation

United States
Memorial Sloan Kettering Cancer Center

Completed

A Study to Assess Thymic Function Using PET/CT and MRI

CD34 Selected Peripheral Blood Stem Cell Graft

United States
Center for International Blood and Marrow Transplant...
National Marrow Donor Program

Completed

The Financial Impact of Allogeneic Stem Cell Transplantation on Patient and Family

Financial Impact of Stem Cell Transplantation

United States
Roswell Park Cancer Institute

Recruiting

Yoga Intervention for the Improvement of Cancer-Related Stress in Cancer Survivors

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia

Hematologic Diseases | Anemia, Sickle Cell | Beta-Thalassemia | Hematopoietic Stem Cell Transplantation

United States, Canada
Astellas Pharma Global Development, Inc.

Completed

A Study to Evaluate a Therapeutic Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seropositive Recipients Undergoing Allogeneic, Hematopoietic Cell Transplant (HCT) (HELIOS)

Cytomegalovirus (CMV)-Positive Recipients | Allogeneic, Hematopoietic Cell Transplant (HCT)

Japan, Korea, Republic of, United States, Canada, Australia, Belgium, France, Germany, Spain, Sweden, Taiwan
Pluristem Ltd.

Completed

Safety Evaluation of Intramuscular Injections of PLX-R18 in Subjects With Incomplete Hematopoietic Recovery Following Hematopoietic Cell Transplantation

Incomplete HCT (Hematopoietic Cell Transplantation)

United States, Israel
Hackensack Meridian Health

Completed

Tandem Auto Stem Cell Transplant With Melphalan Followed by Melphalan and Bortezomib in Patients With Multiple Myeloma ((Mel/MelVel))

Multiple Myeloma | Auto Stem Cell Transplant

United States
Yale University

Completed

Sirolimus, Tacrolimus and Short Course Methotrexate for Prevention of Acute GVHD in Recipients of Mismatched Unrelated Donor Allogeneic Stem Cell Transplantation

Stem Cell Transplantation

United States
Center for International Blood and Marrow Transplant...
Medical College of Wisconsin

Completed

Study of Quality of Life in Older vs. Younger Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes

Myelodysplastic Syndromes | Hematopoietic Cell Transplant

United States
Children's Oncology Group
National Cancer Institute (NCI); Yale University

Active, not recruiting

Mobile Health and Social Media Physical Activity Intervention Among Adolescent and Young Adult Childhood Cancer Survivors, the StepByStep Study

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm

United States, Canada
Roswell Park Cancer Institute

Withdrawn

Thermal Therapy for the Treatment of Depression in Cancer Survivors, the S-WARM Study

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm

United States
Timothy Voorhees

Recruiting

Tafasitamab and Rituximab for Front-Line Treatment of Post-Transplant Lymphoproliferative Disorder

Polymorphic Post-Transplant Lymphoproliferative Disorder | Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder

United States
Roswell Park Cancer Institute
Pfizer

Withdrawn

Inotuzumab Ozogamicin and Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia

Recurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Blasts 5 Percent or More of Bone Marrow Nucleated Cells | CD22 Positive | Allogeneic Hematopoietic Stem Cell Transplantation Recipient | Blasts 5 Percent or More of Peripheral Blood White Cells | Lymphoblasts... and other conditions

United States
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)

Terminated

Gluten Free Diet in Preventing Graft Versus Host Disease in Patients Undergoing Donor Stem Cell Transplant

Graft Versus Host Disease | Hematopoietic Cell Transplantation Recipient

United States
Atara Biotherapeutics

Recruiting

A Study to Evaluate Tabelecleucel in Participants With Epstein-barr Virus-associated Diseases

Lymphoproliferative Disorders | Leiomyosarcoma | Stem Cell Transplant Complications | Solid Organ Transplant Complications | Epstein-Barr Virus (EBV)-Associated Diseases | EBV+ Post-transplant Lymphoproliferative Disease (EBV+ PTLD) | Allogeneic Hematopoietic Cell Transplant | EBV+ Sarcomas | EBV+ Lymphoproliferative... and other conditions

United States, Austria, Belgium, France, Italy, Spain, United Kingdom
Children's Oncology Group
National Cancer Institute (NCI)

Recruiting

Vincristine Pharmacokinetics in Infants

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm

United States, Australia, Canada
medac GmbH
Synteract, Inc.

Recruiting

Effect of Moderate Renal Impairment and Race/Ethnicity on Treosulfan Pharmacokinetics

Myelodysplastic Syndrome (MDS) | Acute Myeloid Leukaemia (AML) | Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

United States
Takeda

Active, not recruiting

A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Participants With Multiple Myeloma Following Autologous Stem Cell Transplant

Multiple Myeloma | Autologous Stem Cell Transplant

United States, Spain, Australia, Czechia, Hungary, Taiwan, Italy, Denmark, Portugal, Singapore, Israel, Canada, France, Belgium, United Kingdom, Germany, Japan, Austria, Netherlands, Korea, Republic of, Poland, Greece, Colombia, Sweden, South Africa and more
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Collection of Bone Marrow From Donors Treated With or Without Filgrastim

No Evidence of Disease | Healthy Stem Cell Donor

United States
All India Institute of Medical Sciences, New Delhi
Indian Council of Medical Research

Unknown

Study of Homing of Labelled Stem Cells in Human Heart. (COLT)

Homing of Stem Cells in the Infarct Area.

India
Northwestern University
National Cancer Institute (NCI); Hackensack Meridian Health; Lombardi Comprehensive...

Completed

Expressive Helping for Stem Cell Transplant Patients

Stem Cell Transplantation | Hematologic Malignancy

United States

Clinical Trials on Hematopoietic Stem Cell Transplant in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malawi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations